Zhejiang Jiuzhou Pharmaceutical Co., Ltd.SSE: 603456

(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Report for Q3 2026

· Issued by Zhejiang Jiuzhou Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603456 · · 12 pages · Chinese

Summary by 6ix AI

The report includes a summary of major accounting data and financial indicators, along with insights into non-recurring gains and losses. It also discusses changes in financial metrics and the reasons behind these variations, particularly a decrease in cash flow from operating activities. The financial statements included in the report are unaudited and cover the period from the beginning of the year to the end of the third quarter.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Jiuzhou Pharmaceutical

Later from Zhejiang Jiuzhou Pharmaceutical

All Zhejiang Jiuzhou Pharmaceutical news releases